Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Cimetidine is not a first-choice treatment for female hair loss, and there's no consistently successful treatment for this condition in men or normal hormone level women.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

A man's baldness improved possibly due to a medication that blocks male hormones.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Minoxidil caused hair to grow in unintended areas, like a tail, in a young girl.

Advancements in technology now allow better evaluation and treatment for women with common hair loss problem, androgenic alopecia.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

BTA safely and effectively treats hair loss, and works better with FNS.